Anders Holt
Overview
Explore the profile of Anders Holt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Holt A, Batinica B, Liang J, Kerr A, Crengle S, Hudson B, et al.
Eur J Prev Cardiol
. 2023 Sep;
31(2):218-227.
PMID: 37767960
Aims: Multiple health administrative databases can be individually linked in Aotearoa New Zealand, using encrypted identifiers. These databases were used to develop cardiovascular risk prediction equations for patients with known...
12.
Sindet-Pedersen C, El-Chouli M, Nouhravesh N, Lamberts M, Christensen D, Kumler T, et al.
Eur Heart J Qual Care Clin Outcomes
. 2023 Aug;
10(3):256-264.
PMID: 37541959
Aim: To identify the absolute risk, causes, and factors associated with rehospitalization within 1 year of discharge with a pulmonary embolism (PE). Methods And Results: Using the Danish nationwide registries,...
13.
Nouhravesh N, Strange J, Holt A, Tonnesen J, Andersen C, Nielsen S, et al.
Eur J Heart Fail
. 2023 Aug;
25(10):1859-1867.
PMID: 37534618
Aim: Expected 1-year survival is essential to risk stratification of patients with heart failure (HF); however, little is known about the 1-year prognosis of patients with HF and cancer. Thus,...
14.
Halili A, Holt A, Eroglu T, Haxha S, Zareini B, Torp-Pedersen C, et al.
Eur Heart J Cardiovasc Pharmacother
. 2023 Jun;
9(6):553-561.
PMID: 37391361
Aims: We studied the effect of discontinuing beta-blockers following myocardial infarction in comparison to continuous beta-blocker use in optimally treated, stable patients without heart failure. Methods And Results: Using nationwide...
15.
Holt A, Strange J, Nouhravesh N, Nielsen S, Malik M, Schjerning A, et al.
J Am Coll Cardiol
. 2023 Apr;
81(15):1459-1470.
PMID: 37045515
Background: Fluid retention and endothelial dysfunction have been related to use of nonsteroidal anti-inflammatory drugs (NSAIDs), and type 2 diabetes mellitus (T2DM) has been linked to both a decline in...
16.
Strange J, Sindet-Pedersen C, Holt A, Andersen M, Torp-Pedersen C, Kober L, et al.
JACC Cardiovasc Interv
. 2023 Jan;
16(2):179-188.
PMID: 36697154
Background: Loss of autonomy associated with nursing home admission (NHA) is a concern for patients. Yet the incidence of NHA after transcatheter aortic valve replacement (TAVR) is unknown. Objectives: The...
17.
Nouhravesh N, Strange J, Tonnesen J, Holt A, Andersen C, Jensen M, et al.
Am Heart J
. 2022 Nov;
256:13-24.
PMID: 36370886
Background: To investigated the prognosis of the most prevalent cancers (breast-, gastrointestinal-, and lung cancer), according to cancer status (i.e., active-, non-active-, history of-, and no cancer), following first-time of...
18.
Holt A, Strange J, Nouhravesh N, McGettigan P, Lamberts M
Am J Med
. 2022 Sep;
135(10):e407-e408.
PMID: 36180184
No abstract available.
19.
Blanche P, Holt A, Scheike T
Lifetime Data Anal
. 2022 Jul;
29(2):441-482.
PMID: 35799026
Simple logistic regression can be adapted to deal with right-censoring by inverse probability of censoring weighting (IPCW). We here compare two such IPCW approaches, one based on weighting the outcome,...
20.
Holt A, Blanche P, Jensen A, Nouhravesh N, Rajan D, Jensen M, et al.
Ann Intern Med
. 2022 Apr;
175(6):774-782.
PMID: 35436155
Background: Concomitant use of oral organic nitrates (nitrates) and phosphodiesterase type 5 (PDE5) inhibitors is contraindicated. Objective: To measure temporal trends in the coprescription of nitrates and PDE5 inhibitors and...